Pfizer may not expand in U.S. due to drug pricing orders
Pfizer is reconsidering its initial plan to expand in the United States due to possible drug pricing orders, Yahoo! Finance reported.
Chief Executive Albert Bourla said that Pfizer might rethink its plans if President Donald Trump's executive order is implemented tying prices Medicare patients pay for prescriptions to prices other countries pay, the news media reported.
"These new executive orders could force us to rethink those plans, consider job reductions and add to the economic and health anxiety already widely felt in our country," Bourla said on the company's earnings conference call, Yahoo reported.